In the two patients carrying homozygous 22q11.1 deletion, encompassing both copies of the IL-17 receptor A (IL17RA) and the CECR1 gene, the clinical phenotype was dominated by muco-cutaneous infections and dermatitis associated to persistent inflammation and, in one patient, vasculitis responding to steroids [14]. This evidence concerns the gene IL17RA and vasculitis.